Stryker Corporation (SYK): Stryker Continues Steady Sale

0

Ronda E. Stryker, Director at Stryker Corporation (NYSE:SYK) disclosed today the disposal of 14,000 shares through two transactions on October 28, 2014. The first, involved 7,000 shares at a unit price of $84.6436, and the remaining shares were sold at $86.6953 each.  Mrs. Stryker has been selling compulsively since mid-2014, and now directly owns 174,605 and an additional 38,247,762 shares.

Steven P. Benscoter, Vice President of Human Resources at Stryker Corporation (NYSE:SYK) has also been trading the stock. Mr. Benscoter sold a total of 26,464 shares through three different transactions at prices ranging from $76.87 to $79.97, and now owns a total of 8,742 shares.

Donald Yacktman’s Yacktman Asset Management is the largest shareholding institution (amongst those we track) at Stryker Corporation (NYSE:SYK) with 10,178,928 shares, valued at an estimate $858 million, after reporting a 13% holding reduction for the second filling period of 2014.

Stryker Corporation (NYSE:SYK) is a medical technology company that offers a diverse array of medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products.

Disclosure: The author, Jodor Jalit, holds no position in any stocks or funds mentioned.

Suggested Articles:

Examples of Genetically Modified Organisms

Healthiest Countries

Share.